103 related articles for article (PubMed ID: 15204309)
1. Biomonitoring of chromium(VI) deposited in pulmonary tissues: pilot studies of a magnetic resonance imaging technique in a post-mortem rodent model.
Shayer R; Kinchesh P; Raffray M; Kortenkamp A
Biomarkers; 2004; 9(1):32-46. PubMed ID: 15204309
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of an intratracheally administered chromium catalyst in rats.
Vanoirbeek JA; Hoet PH; Nemery B; Verbeken EK; Haufroid V; Lison D; Dinsdale D
J Toxicol Environ Health A; 2003 Feb; 66(4):393-409. PubMed ID: 12554544
[TBL] [Abstract][Full Text] [Related]
3. [Serum and erythrocyte chromium distribution and urinary elimination in persons occupationally exposed to chromium (VI) and chromium (III)].
Cavalleri A; Minoia C
G Ital Med Lav; 1985 Jan; 7(1):35-8. PubMed ID: 4076713
[TBL] [Abstract][Full Text] [Related]
4. Chromium(VI)-induced DNA lesions and chromium distribution in rat kidney, liver, and lung.
Tsapakos MJ; Hampton TH; Wetterhahn KE
Cancer Res; 1983 Dec; 43(12 Pt 1):5662-7. PubMed ID: 6640521
[TBL] [Abstract][Full Text] [Related]
5. Chromium in exhaled breath condensate (EBC), erythrocytes, plasma and urine in the biomonitoring of chrome-plating workers exposed to soluble Cr(VI).
Goldoni M; Caglieri A; De Palma G; Acampa O; Gergelova P; Corradi M; Apostoli P; Mutti A
J Environ Monit; 2010 Feb; 12(2):442-7. PubMed ID: 20145884
[TBL] [Abstract][Full Text] [Related]
6. A physiologically based model of chromium kinetics in the rat.
O'Flaherty EJ
Toxicol Appl Pharmacol; 1996 May; 138(1):54-64. PubMed ID: 8658513
[TBL] [Abstract][Full Text] [Related]
7. Problems in the biological monitoring of chromium(VI) exposed individuals.
Kortenkamp A
Biomarkers; 1997; 2(2):73-9. PubMed ID: 23889062
[TBL] [Abstract][Full Text] [Related]
8. Using non-invasive magnetic resonance imaging (MRI) to assess the reduction of Cr(VI) using a biofilm-palladium catalyst.
Beauregard DA; Yong P; Macaskie LE; Johns ML
Biotechnol Bioeng; 2010 Sep; 107(1):11-20. PubMed ID: 20506297
[TBL] [Abstract][Full Text] [Related]
9. Exposure to low levels of hexavalent chromium: target doses and comparative effects on two human pulmonary cell lines.
Caglieri A; Goldoni M; De Palma G; Mozzoni P; Gemma S; Vichi S; Testai E; Panico F; Corradi M; Tagliaferri S; Costa LG
Acta Biomed; 2008; 79 Suppl 1():104-15. PubMed ID: 18924316
[TBL] [Abstract][Full Text] [Related]
10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
11. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect.
Pauluhn J
Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke.
Petrilli FL; Rossi GA; Camoirano A; Romano M; Serra D; Bennicelli C; De Flora A; De Flora S
J Clin Invest; 1986 Jun; 77(6):1917-24. PubMed ID: 2423559
[TBL] [Abstract][Full Text] [Related]
13. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
14. Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses.
De Flora S; Iltcheva M; Balansky RM
Mutat Res; 2006 Nov; 610(1-2):38-47. PubMed ID: 16872865
[TBL] [Abstract][Full Text] [Related]
15. Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months.
Arts JH; Muijser H; Duistermaat E; Junker K; Kuper CF
Food Chem Toxicol; 2007 Oct; 45(10):1856-67. PubMed ID: 17524541
[TBL] [Abstract][Full Text] [Related]
16. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D;
Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053
[TBL] [Abstract][Full Text] [Related]
17. Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study.
Hegenscheid K; Kühn JP; Völzke H; Biffar R; Hosten N; Puls R
Rofo; 2009 Aug; 181(8):748-59. PubMed ID: 19598074
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared fluorescence imaging and histology confirm anomalous edematous signal distribution detected in the rat lung by MRI after allergen challenge.
Tigani B; Gremlich HU; Cannet C; Zurbruegg S; Quintana HK; Beckmann N
J Magn Reson Imaging; 2004 Dec; 20(6):967-74. PubMed ID: 15558573
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging for detection and analysis of mouse phenotypes.
Nieman BJ; Bock NA; Bishop J; Chen XJ; Sled JG; Rossant J; Henkelman RM
NMR Biomed; 2005 Nov; 18(7):447-68. PubMed ID: 16206127
[TBL] [Abstract][Full Text] [Related]
20. Subchronic inhalation toxicity of soluble hexavalent chromium trioxide in rats.
Kim HY; Lee SB; Jang BS
Arch Toxicol; 2004 Jul; 78(7):363-8. PubMed ID: 15205887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
